Literature DB >> 16997856

Cytokine-induced killer T cells kill immature dendritic cells by TCR-independent and perforin-dependent mechanisms.

Pramod S Joshi1, Jin-Qing Liu, Yin Wang, Xing Chang, John Richards, Erika Assarsson, Fu-Dong Shi, Hans-Gustaf Ljunggren, Xue-Feng Bai.   

Abstract

Cytokine-induced killer (CIK) cells are ex vivo, expanded T cells with proven anticancer activity in vitro and in vivo. However, their functional properties with the exception of their cancer cell-killing activity are largely unclear. Here, we show that CIK T cells recognize dendritic cells (DC), and although mature DC (mDC) induce CIK T cells to produce IFN-gamma, immature DC (iDC) are killed selectively by them. Moreover, CIK T cell activation by mDC and their destruction of iDC are independent of the TCR. The cytotoxicity of CIK T cells to iDC is perforin-dependent. Our data have revealed an important regulatory role of CIK cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16997856     DOI: 10.1189/jlb.0506305

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  13 in total

Review 1.  Review of Chinese clinical trials on CIK cell treatment for malignancies.

Authors:  Xiao-Dong Li; Bin Xu; Jun Wu; Mei Ji; Bei-Hua Xu; Jing-Ting Jiang; Chang-Ping Wu
Journal:  Clin Transl Oncol       Date:  2012-02       Impact factor: 3.405

2.  Meta-analysis of chemotherapy and dendritic cells with cytokine-induced killer cells in the treatment of non-small-cell lung cancer.

Authors:  Chenhong Zheng; Ganjun Yu; Hui Wang; Airong Tang; Peiliang Geng; Huiming Zhang; Zhiquan Zhu; Fang Li; Xiaohua Xie
Journal:  Int J Clin Exp Med       Date:  2015-08-15

3.  Efficient lysis of rhabdomyosarcoma cells by cytokine-induced killer cells: implications for adoptive immunotherapy after allogeneic stem cell transplantation.

Authors:  Selim Kuçi; Eva Rettinger; Bernhard Voss; Gerrit Weber; Miriam Stais; Hermann Kreyenberg; Andre Willasch; Zyrafete Kuçi; Ewa Koscielniak; Stephan Klöss; Dorothee von Laer; Thomas Klingebiel; Peter Bader
Journal:  Haematologica       Date:  2010-04-07       Impact factor: 9.941

4.  Increased survival time of a patient with metastatic malignant melanoma following immunotherapy: A case report and literature review.

Authors:  Yong Zhang; Yongping Song; Quanli Gao
Journal:  Oncol Lett       Date:  2015-05-29       Impact factor: 2.967

5.  IL-27 enhances the survival of tumor antigen-specific CD8+ T cells and programs them into IL-10-producing, memory precursor-like effector cells.

Authors:  Zhenzhen Liu; Jin-Qing Liu; Fatemeh Talebian; Lai-Chu Wu; Shulin Li; Xue-Feng Bai
Journal:  Eur J Immunol       Date:  2013-01-15       Impact factor: 5.532

6.  Effect of cytokine-induced killer cells on immune function in patients with lung cancer.

Authors:  Yanyan Pan; Yuanyuan Wu; Jun Ji; Hongjiao Cai; Heshuang Wang; Yifan Jiang; Limin Sang; Jin Yang; Yanyan Gao; Ying Liu; Liangwei Yin; L I Zhang
Journal:  Oncol Lett       Date:  2016-02-29       Impact factor: 2.967

7.  Efficacy of adjuvant immunotherapy with cytokine-induced killer cells in patients with locally advanced gastric cancer.

Authors:  Liangrong Shi; Qi Zhou; Jun Wu; Mei Ji; Guojun Li; Jingting Jiang; Changping Wu
Journal:  Cancer Immunol Immunother       Date:  2012-06-07       Impact factor: 6.968

Review 8.  Evaluation of tumor response to cytokine-induced killer cells therapy in malignant solid tumors.

Authors:  Xiao-Dong Li; Mei Ji; Xiao Zheng; Zhong-Hua Ning; Jun Wu; Binfeng Lu; Chang-Ping Wu; Jing-Ting Jiang
Journal:  J Transl Med       Date:  2014-08-12       Impact factor: 5.531

9.  Cytokine-induced killer cell therapy for advanced pancreatic adenocarcinoma: A case report and review of the literature.

Authors:  Wei Li; Lin Ping Xu; Ling DI Zhao; Li Wang; Yong Zhang; Quan Li Gao; Ling Mai
Journal:  Oncol Lett       Date:  2013-02-19       Impact factor: 2.967

10.  Immune response, clinical outcome and safety of dendritic cell vaccine in combination with cytokine-induced killer cell therapy in cancer patients.

Authors:  Yu Cui; Xuejing Yang; Wei Zhu; Jiali Li; Xiaojing Wu; Yan Pang
Journal:  Oncol Lett       Date:  2013-06-04       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.